Acuta Capital Partners’s Trevi Therapeutics TRVI Stock Holding History

Acuta Capital Partners’s Portfolio TRVI Stock Details TRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.7M	Sell
2025 Q1	$4.94M	Buy
2024 Q4	$3.18M	Buy
2024 Q3	$970K	Buy
2024 Q2	$775K	Buy
2022 Q4	–	Sell
2022 Q3	$56K	Buy
2022 Q2	$98K	Buy